News

Ophthalmology Times1d
ARVO 2025: Shortened, maintained, or extended dosing intervals through 96 weeks in PHOTON
At ARVO 2025, in Salt Lake City, Utah, Dilsher Dhoot, MD, FASRS, and Mark Barakat, MD, talked about the PHOTON trial, 8 mg ...
Sanofi Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs Late-breaking data show infant respiratory syncytial virus (RSV) hospitalizat ...
finanzen.at2d
Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs Late-breaking data ...
The Next Big Theme: May 2025
Big Tech players will collectively spend over $300 billion on AI-focused infrastructure this year to support the growing ...
BMJ6d
Optimal dose and type of physical activity to improve functional capacity and minimise adverse events in acutely hospitalised older adults: a systematic review with dose ...
Using novel meta-analytical techniques (ie, model-based dose-response network meta-analysis under a Bayesian framework) and evidence from existing randomised controlled trials ... physical activity ...
BMJ8d
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
Background Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA), interleukin 6 (IL-6) pathway inhibition was evaluated in trials of ...
AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025
AZTR READ THE FULL AZTR RESEARCH REPORT Azitra, Inc. (NYSE:AZTR) reported first quarter 2025 results in a May 13 th  press ...
thorax.bmj10d
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial
We evaluated the effects on health outcomes of replacing CXR by ultra-low-dose chest-CT (ULDCT ... Methods Pragmatic, multicentre, non-inferiority randomised clinical trial in patients suspected of ...
Medscape14d
Comparison of Three A Priori Methods and One Empirical Method in Predicting Lithium Dosage Requirements
The precision and bias of three a priori methods and an empirical method for predicting lithium dosage requirements were studied. Data on serum lithium concentrations were collected from inpatient ...
SciELO15d
Comparison of totally tubeless percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for kidney stones: a randomized, clinical trial
The study was designed as a randomized, clinical trial (IRCT: 201407256803N8 ... in the totally tubeless PCNL group required pethidine. The mean dose of pethidine that was administered to the standard ...
The Lancet15d
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre ...
rNIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK sUniversity Hospitals Sussex NHS Foundation Trust, ...
Cancer Research16d
Radiation Dose–Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy
1Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. 3Shanghai Clinical ...